Pernicious anemia: new insights from a gastroenterological point of view - PubMed (original) (raw)

Review

Pernicious anemia: new insights from a gastroenterological point of view

Edith Lahner et al. World J Gastroenterol. 2009.

Abstract

Pernicious anemia (PA) is a macrocytic anemia that is caused by vitamin B(12) deficiency, as a result of intrinsic factor deficiency. PA is associated with atrophic body gastritis (ABG), whose diagnosis is based on histological confirmation of gastric body atrophy. Serological markers that suggest oxyntic mucosa damage are increased fasting gastrin and decreased pepsinogen I. Without performing Schilling's test, intrinsic factor deficiency may not be proven, and intrinsic factor and parietal cell antibodies are useful surrogate markers of PA, with 73% sensitivity and 100% specificity. PA is mainly considered a disease of the elderly, but younger patients represent about 15% of patients. PA patients may seek medical advice due to symptoms related to anemia, such as weakness and asthenia. Less commonly, the disease is suspected to be caused by dyspepsia. PA is frequently associated with autoimmune thyroid disease (40%) and other autoimmune disorders, such as diabetes mellitus (10%), as part of the autoimmune polyendocrine syndrome. PA is the end-stage of ABG. Long-standing Helicobacter pylori infection probably plays a role in many patients with PA, in whom the active infectious process has been gradually replaced by an autoimmune disease that terminates in a burned-out infection and the irreversible destruction of the gastric body mucosa. Human leucocyte antigen-DR genotypes suggest a role for genetic susceptibility in PA. PA patients should be managed by cobalamin replacement treatment and monitoring for onset of iron deficiency. Moreover, they should be advised about possible gastrointestinal long-term consequences, such as gastric cancer and carcinoids.

2009 The WJG Press and Baishideng. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Age cohorts of a series of patients with PA (n = 177) consecutively diagnosed between 1992 and 2005 at an academic gastroenterology unit.

Figure 2

Figure 2

Diagnostic flow-chart for PA.

Comment in

Similar articles

Cited by

References

    1. Zittoun J. [Biermer's disease] Rev Prat. 2001;51:1542–1546. - PubMed
    1. Meecham J, Jones EW. Addison's disease and Addisonian anaemia. Lancet. 1967;1:535–538. - PubMed
    1. Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Foerster J, Athens JW, Lukens JN. Megaloblastic and nonmegaloblastic macrocytic anemias. In: Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Foerster J, et al., editors. Clinical hematology. 8th ed. Philadelphia: Lea & Febiger; 1981. pp. 559–604.
    1. Lee EL, Feldman M. Gastritis and other gastropathies. In: Feldman M, Friedman LS, Sleisenger MH, et al., editors. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 7th ed. Philadelphia: Saunders; 2002. pp. 810–827.
    1. Babior BM. Erythrocyte disorders: Anemias related to disturbance of DNA synthesis (megaloblastic anemias) In: Williams JW, Beutler E, Erslev AJ, Lichtman MA, et al., editors. Hematology. 4th ed. New York: McGraw-Hill; 1998. pp. 453–481.

Publication types

MeSH terms

Substances

LinkOut - more resources